Compare AYTU & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AYTU | CYN |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | 62 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4M | 22.9M |
| IPO Year | 2015 | 2021 |
| Metric | AYTU | CYN |
|---|---|---|
| Price | $2.36 | $1.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.33 | N/A |
| AVG Volume (30 Days) | 27.3K | ★ 145.9K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,632,080.00 | $368,138.00 |
| Revenue This Year | N/A | $3,359.28 |
| Revenue Next Year | $43.75 | $347.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 277.47 | N/A |
| 52 Week Low | $1.65 | $1.03 |
| 52 Week High | $3.07 | $6.82 |
| Indicator | AYTU | CYN |
|---|---|---|
| Relative Strength Index (RSI) | 59.94 | 41.97 |
| Support Level | $2.11 | N/A |
| Resistance Level | $2.46 | $1.40 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 76.47 | 12.00 |
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
Cyngn Inc is an industrial autonomous vehicle technology company, focused on addressing industrial uses for autonomous vehicles. It develops full-stack autonomous driving software, DriveMod, which is integrated into vehicles manufactured by original equipment manufacturers during the assembly process. The company designs its software to be compatible with a range of sensors and hardware components and integrates it with its own systems to enable autonomous vehicle functionality.